PAP
Pulmonary alveolar proteinosis (PAP) is a rare disease of unknown cause. It is characterized by the deposition of insoluble phospholipid-rich proteins in the alveoli, and the main clinical symptoms are shortness of breath, cough and sputum. Chest X-ray shows diffuse pulmonary infiltration shadows in both lungs. Pathological examination is characterized by alveoli filled with protein-like substances that are positive for periodic acid-Schiff (PAS) staining. The disease was first reported by Rosen in 1958. Pulmonary alveolar proteinosis can be divided into primary, secondary and congenital according to the cause.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
The male-to-female ratio is 2 to 3:1, and can occur in... -
Related symptoms:
Alveolar inflammation chest pain fatigue dyspnea cyanosis -
Concurrent disease:
Related Drugs
Sulfadiazine Suspension
Indication: Used for infections such as hemolytic streptococci, meningococci, and pneumococci.
Manufacturer:
Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd.
Related Ingredients